Skip to content

A nurse-led sexual rehabilitation intervention for gynaecological cancer survivors

Rebuilding sexuality and intimacy after treatment for gynaecological cancer, through a nurse-led sexual rehabilitation intervention: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN44439658
Enrollment
172
Registered
2019-09-06
Start date
2019-07-11
Completion date
Unknown
Last updated
2023-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary gynaecological cancer (uterine, ovarian or cervical cancers) Cancer

Interventions

A total of four sessions of individual or couple-based counselling were conducted by a nurse, who had received training in sexual rehabilitation, motivational interviewing skills and cognitive-behavio

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women newly diagnosed with primary GC (uterine, ovarian or cervical cancers) over the past three months 2. Not in the terminal stage of the disease 3. With a regular sexual partner 4. Over 18 5. Able to understand spoken Cantonese and to read Chinese 6. Consenting to participate

Exclusion criteria

Exclusion criteria: Those with unsuitable physical or mental health conditions, or a known pre-existing psychotic illness

Design outcomes

Primary

MeasureTime frame
Sexual functioning is measured by the Chinese version of Sexual Function-Vaginal Changes Questionnaire (SVQ) at baseline (T0), one month after the completion of cancer treatment (T1), on the completion of the intervention (T2) and 12 months after cancer treatment (T3).

Secondary

MeasureTime frame
1. Marital satisfaction is measured by the Chinese version of ENRICH Marital Satisfaction Scale (EMS) at baseline (T0), one month after the completion of cancer treatment (T1), on the completion of the intervention (T2) and 12 months after cancer treatment (T3). 2. Sexual distress is measured by the Chinese version of Female Sexual Distress Scale-Revised (FSDS-R) at baseline (T0), one month after the completion of cancer treatment (T1), on the completion of the intervention (T2) and 12 months after cancer treatment (T3).

Countries

Hong Kong

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026